Dr. Tanyi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Civic Center Boulevard
3rd Floor
Philadelphia, PA 19104Phone+1 215-662-3318Fax+1 215-349-5680- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 2008 - 2011
- Baylor College of MedicineResidency, Obstetrics and Gynecology, 2004 - 2008
- University of Debrecen Medical and Health Science CenterClass of 1993
Certifications & Licensure
- TX State Medical License 2012 - 2026
- NJ State Medical License 2021 - 2025
- PA State Medical License 2008 - 2024
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Autologous OC-DC Vaccine in Ovarian Cancer Start of enrollment: 2010 May 01
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer Start of enrollment: 2011 Mar 01
- CAR T Cells in Mesothelin Expressing Cancers Start of enrollment: 2017 Apr 06
Publications & Presentations
PubMed
- CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now?Erin George, Clare Cutri-French, Dimitrios Nasioudis, Janos L Tanyi> ;Diagnostics. 2024 Apr 16
- Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study.Madeline T Olson, Brian Madajewski, Brian Ostrander, Kartik Krishnan, Patrick Wagner, Edward A Levine, Alex C Kim, Perry Shen, Nicole D Fleming, Shannon N Westin, Laur...> ;Annals of Surgical Oncology. 2024 Apr 15
- 3 citationsA phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer.Sara Bobisse, Valentina Bianchi, Janos L Tanyi, Apostolos Sarivalasis, Edoardo Missiaglia, Rémy Pétremand, Fabrizio Benedetti, Drew A Torigian, Raphael Genolet, David ...> ;Nature Cancer. 2023 Oct 1
- Join now to see all
Press Mentions
- Positive Phase 2 Study Results Published for on Target's Intraoperative Cancer Imaging AgentOctober 15th, 2019
- IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free SurvivalJune 1st, 2019
- Triggering an Immune Response in Ovarian CancerJuly 12th, 2018
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Hungarian
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
- Pennsylvania HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: